Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Should not alter cardiomyopathy management; leaves open dystrophin’s myofibrillar roles for targeted research.
Meng et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: